Related Experiment Video

Updated: May 28, 2026

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
07:21

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on: May 2, 2022

MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation

Won Kyu Kim1, Misun Park, Young-Kook Kim

  • 1Department of Pathology, Yonsei, University College of Medicine, Seoul 120752, Korea.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|November 2, 2011
PubMed
Abstract

Insights

MicroRNA-494 (miR-494) negatively regulates KIT expression in gastrointestinal stromal tumors (GIST). Overexpressing miR-494 in GIST may offer a novel therapeutic strategy for this cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gain-of-function mutations and KIT overexpression are key drivers in gastrointestinal stromal tumor (GIST) development.
  • Identifying regulatory mechanisms of KIT is crucial for understanding GIST tumorigenesis.

Purpose of the Study:

  • To discover microRNAs (miRNAs) that target KIT.
  • To elucidate the relationship between identified miRNAs and KIT expression in GISTs.

Main Methods:

  • Quantitative reverse transcription-PCR and Western blotting were used to assess miR-494 and KIT expression in GIST samples.
  • Luciferase assays confirmed direct targeting of KIT by miR-494.
  • Functional effects were evaluated using cell proliferation and apoptosis assays in GIST cell lines.

Main Results:

  • An inverse correlation between miR-494 and KIT expression was observed in GISTs.
  • miR-494 directly targets KIT by binding to specific seed sites, reducing KIT protein levels.
  • Overexpression of miR-494 inhibited GIST cell growth and induced apoptosis by downregulating KIT signaling pathways.

Conclusions:

  • miR-494 acts as a negative regulator of KIT in GIST.
  • Therapeutic strategies involving miR-494 overexpression present a promising avenue for GIST treatment.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...